- Home
- CSCI vs MCVT Comparison
CSCI vs MCVT Comparison
Compare CSCI & MCVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSCI
- MCVT
- Stock Information
- Founded
- CSCI 1990
- MCVT 2007
- Country
- CSCI Canada
- MCVT United States
- Employees
- CSCI N/A
- MCVT N/A
- Industry
- CSCI
- MCVT Finance Companies
- Sector
- CSCI
- MCVT Finance
- Exchange
- CSCI NYSE
- MCVT Nasdaq
- Market Cap
- CSCI 12.5M
- MCVT 14.7M
- IPO Year
- CSCI 1996
- MCVT N/A
- Fundamental
- Price
- CSCI $3.70
- MCVT $2.13
- Analyst Decision
- CSCI
- MCVT
- Analyst Count
- CSCI 0
- MCVT 0
- Target Price
- CSCI N/A
- MCVT N/A
- AVG Volume (30 Days)
- CSCI 5.3K
- MCVT 133.2K
- Earning Date
- CSCI 11-07-2024
- MCVT 11-15-2024
- Dividend Yield
- CSCI N/A
- MCVT N/A
- EPS Growth
- CSCI N/A
- MCVT N/A
- EPS
- CSCI N/A
- MCVT 0.04
- Revenue
- CSCI $4,915,000.00
- MCVT $3,248,401.00
- Revenue This Year
- CSCI N/A
- MCVT N/A
- Revenue Next Year
- CSCI N/A
- MCVT N/A
- P/E Ratio
- CSCI N/A
- MCVT $58.52
- Revenue Growth
- CSCI N/A
- MCVT N/A
- 52 Week Low
- CSCI $3.49
- MCVT $2.10
- 52 Week High
- CSCI $11.10
- MCVT $3.88
- Technical
- Relative Strength Index (RSI)
- CSCI N/A
- MCVT 36.04
- Support Level
- CSCI N/A
- MCVT $2.23
- Resistance Level
- CSCI N/A
- MCVT $2.47
- Average True Range (ATR)
- CSCI 0.00
- MCVT 0.30
- MACD
- CSCI 0.00
- MCVT -0.08
- Stochastic Oscillator
- CSCI 0.00
- MCVT 0.00
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.
About MCVT Mill City Ventures III Ltd.
Mill City Ventures III Ltd is a non-bank lender and specialty finance company. The company is engaged in the business of providing short-term specialty finance solutions primarily to private businesses, micro-and small-cap public companies, and high-net-worth individuals. The principal specialty finance solutions that they provide are high-interest short-term lending arrangements. Typically, these lending arrangements involve obtaining collateral as security for the borrower's repayment of funds, or personal guarantees from the principals or affiliates of the borrower.